Healthcare Innovations: WeightWatchers' Amazon Deal and Glaukos' FDA Approval
Published on: Oct. 21, 2025, 2:30 a.m. | Source: Devdiscourse
WeightWatchers partners with Amazon to streamline delivery of weight-loss drugs, boosting its stock by 9%. Meanwhile, Glaukos receives FDA approval for a new eye therapy offering a less painful treatment option, increasing its shares by 2.6%. These developments highlight significant advancements in health and telemedicine.
